408-854-1883 starts at $30 per hr home care

Affordable in home care | starts at $28 per hr

Health risk factor = others + genes

Alzheimer’s disease risk factor

Sex
Male = 0.05
Female =0.1
Age > 55yrs=0.1
< 55yrs = 0.05
Blood sugar
Normal/low =0High = 0.1
Med =0.05
Blood Pressure
Normal/low=0
High = 0.1
Med =0.05
Exposure to copper,fungus,molds,toxins, smoking,alcohol,narcotics, aluminum, air pollution, medications > 5
(H,M,L)  0.2 = H,M = 0.1
Metabolic and diet:
Diabetes 0.1
Exercise and sun exposure, 3x per week = 0
No exercise = 0.1
Genes:
0.1 (combo of these genes) –
Aβ42 ;  presenilin 1 & 2 ; APP ;  CASS4  CELF1  FERMT2
HLA-DRB5, INPP5D,
MEF2C, NME8, PTK2B,
SORL1, ZCWPW1,SlC24A4,
CLU, PICALM, CR1, BIN1,
MS4A, ABCA7,
EPHA1, and CD2AP
Weak immune and metabolic system:
Infection and allergy 0.1Stress level and brain concussions (H,M,L)
H = 0.1
L=0

Blood cancer risk factor

Sex
Male = 0.2
Female =0.1
Age > 15yrs=0.2
15yrs <= 0.1
Race = 0.1 (south asian)
Prenatal exposure to x-rays, chemicals, medications/drugs, alcohol = 0.2 Environmental toxins, therapeutic radiation , non-ionizing radiation,; previous cancer treatment: Certain types of chemotherapy and radiation therapy for other

 

Metabolic and diet:
Diabetes 0.1
smoking  = 0.1 Specific genetic syndromes ; Down syndrome = 0.1

Polymorphic alleles of the human leukocyte antigen (HLA) class II genes = 0.1

Weak immune and metabolic system:
Infection and allergy 0.1

Colon and other cancers risk factor

Blood sugar
Normal/low =0High = 0.2
Med =0.1
Previous history of cancer/bowel disease, family cancer/polyps
Normal/low=0
High = 0.1
Race = 0.1 racial/ethnic background (African American, Eastern European Jews)
Exercise and sun exposure, 3x per week = 0
No exercise = 0.1
Exposure to copper,fungus,molds,toxins, smoking,alcohol,narcotics, aluminum, air pollution, char broiled meat, aflatoxin, virus,bacteria, medications > 5
(H,M,L)
Yes = H,M = 0.1
Metabolic and diet:
Diabetes 0.1Night time work, obesity (H,M,L)
H = 0.1
Age > 45 yrs old Genes:
0.2 = MSH2, MLH1, MSH6, PMS2, PMS1, TGFBR2, MLH3 , RCC, APC, HPC1, tmprss2-erg ,  TMPRSS2-ETV1/4, HBOC,BRCA,BRCA2,BRCA1
(0.2 more than 2 genes, 0.1 one gene),
Weak immune and metabolic system:
Infection and allergy 0.1

Join 25,000 people in helping redefine health with health concierge and precision medicine.

https://clubalthea.com/2016/10/14/your-complete-dna-sequence-will-help-shape-the-future-of-medicine/

Colorectal, ovarian-uterine, prostate, kidney, liver and bladder cancer risk Factor

COPKL: Colorectal, ovarian/uterine, prostate, kidney, liver and bladder cancer risk Factor, formula by Connie Dello Buono , ©12Sept2016 Assumption: Female/Male, over 50yrs of age, on western diet, …

Source: Colorectal, ovarian-uterine, prostate, kidney, liver and bladder cancer risk Factor

Stanford-led Team Finds Non-African Human Populations Harbor Higher Mutational Loads

Stanford’s Carlos Bustamante and his colleagues analyzed the genomes and exomes of seven geographically divergent human populations — from Namibia, Congo, Algeria, Pakistan, Cambodia, Siberia…

Source: Stanford-led Team Finds Non-African Human Populations Harbor Higher Mutational Loads

Stanford-led Team Finds Non-African Human Populations Harbor Higher Mutational Loads

Stanford’s Carlos Bustamante and his colleagues analyzed the genomes and exomes of seven geographically divergent human populations — from Namibia, Congo, Algeria, Pakistan, Cambodia, Siberia, and Mexico — and found that while the number of deleterious alleles in each individual varies only a little, classes of deleterious alleles show different patterns across those populations. These patterns seem to stem from the interaction of genetic drift and purifying selection, as the researchers reported in the Proceedings of the National Academy of Sciences this week.

“By directly ascertaining genomic variation in over 50 individuals from seven populations, we observe a clear cline of genetic diversity as a function of distance from Africa, supporting evidence for a serial founder effect model,” Bustamante and his colleagues wrote in their paper. “We also observe differences in the amount of predicted deleterious variation across populations.”

The researchers drew on a dataset of moderate, median 7X depth coverage whole-genome sequence and high, median 78X depth coverage exome sequence data from unrelated people belonging to seven populations represented in the Human Genome Diversity Panel.

Heterozygosity, the researchers found, decreases among the seven populations with increasing geographical distance from southern Africa. For instance, they noted that the Namibian San population harbored the highest amount of derived heterozygotes, about 2.39 million per sample, as compared to about 1.5 million among the Maya in Mexico.

This decline in heterozygosity with distance from Africa, they said, supports earlier SNP array- and microsatellite-based work that suggested a serial founder effect model for the ancestral populations of Eurasia, Oceania, and the Americas.

Using a pairwise sequential Markovian coalescent software-based analysis, the researchers further found that the out-of-Africa populations experienced a deep decline in effective population size, as previous analyses had also indicated.

Based on their Genomic Evolutionary Rate Profiling (GERP) Rejected Substitution scores, Bustamante and his colleagues classified the mutations they uncovered in the exome dataset into one of four categories, reflecting the projected severity of their effects. From this, the researchers found that the number of predicted deleterious alleles per individual increased with geographical distance from Africa, a pattern that is also consistent with serial bottlenecks or founder effects. The average, additive GERP score ranged from about 3.3 in the San to about 3.8 in the Maya, they added.

At the same time, Bustamante and his colleagues reported that there was no difference in putatively moderate or extremely deleterious effect variants between African and out-of-Africa populations in terms of the number of mutations per individual.

Using a new statistic they developed called RH that measures the reduction in heterozygosity at conserved sites as compared to neutral heterozygosity, Bustamante and his team examined how evolutionary forces acted on different human populations to shape their patterns of genetic diversity. A constant RH value, for instance, reflects genetic drift and migration, while a changing RH implies selection.

In their dataset, they found that RH is much larger among sub-Saharan Africans that in out-of-Africa populations for all functional GERP categories, indicating that selection has acted differently relative to drift on these two groups. This, they added, indicates that purifying selection has kept strongly deleterious alleles at lower frequency in African versus out-of-Africa populations.

Further, the out-of-Africa RH values for moderate-effect alleles don’t depend on their geographical distance from Africa, suggesting that such moderate mutations evolved according to neutral demographic processes during the expansion out of Africa.

Meanwhile, the researchers noted a cline in RH values for deleterious variants with distance from Africa that they said is consistent with unequal purging of deleterious variants by selection after they experienced drift during the out-of-Africa expansion.

Further, in a model in which selection was inversely related to dominance — most large-effect variants are recessive — Bustamante and his colleagues found that out-of-Africa populations are more likely to have a higher mutation load because of increased allele frequencies of recessive or partially recessive neutral variants.

“Whereas previous comparisons between African and non-African diversity attributed the observed increased proportion of deleterious variants in non-Africans to the [out-of-Africa] bottleneck, our study shows that a single bottleneck is not sufficient to reproduce the gradient we observe in the number of deleterious alleles per individual with distance from Africa,” the researchers added.


Join 25,000 people in helping redefine health with health concierge and precision medicine.

https://clubalthea.com/2016/10/14/your-complete-dna-sequence-will-help-shape-the-future-of-medicine/

The African Genome Variation Project shapes medical genetics in Africa

In addition to genes known to be under positive selection (for example, SLC24A5, SLC45A2 andOCA219, 20, LARGE21 and CYP3A4/5) (Supplementary Fig. 3), we found evidence of differentiation in novel gene regions, including one implicated in malaria (for chemokine receptor 1, CR1) (Extended Data Fig. 8). CR1 carries the Knops blood group antigens and has previously been implicated in malaria susceptibility22 and severity23, with evidence suggesting positive selection in malaria-endemic regions24 (Extended Data Fig. 8). We also identified highly differentiated variants within genes involved in osmoregulation (ATP1A1 and AQP2) (Extended Data Fig. 8). Deregulation of AQP2 expression and loss-of-function mutations in ATP1A1 have been associated with essential and secondary hypertension, respectively25, 26. Climatic adaptive changes in these gene regions could potentially provide a biological basis for the high burden of hypertension and differences in salt sensitivity observed in SSA27.

http://www.nature.com/nature/journal/v517/n7534/full/nature13997.html

In contrast, overall differentiation among African populations was modest (maximum masked FST= 0.19) (Supplementary Fig. 4) and only 56/1,237 sites remained in the tail distribution after masking (Supplementary Methods, Supplementary Table 6). This suggests that a large proportion of differentiation observed among African populations could be due to Eurasian admixture, rather than adaptation to selective forces (Supplementary Note 6). Genes known to be under selection were notably enriched among the most differentiated loci after masking of Eurasian ancestry (P = 2.3 × 10−16). Among the 56 loci robust to Eurasian ancestry masking (Supplementary Table 6), we identified several loci known to be under selection (Extended Data Fig. 8), including a highly differentiated variant (rs1378940) in the CSK gene region implicated in hypertension in genome-wide association studies (GWAS)28. The major allele of rs1378940 among Africans was in complete linkage disequilibrium with the risk allele of the GWAS SNP rs1378942 (ref. 29), with the frequency of this allele highly correlated with latitude (r = −0.67), providing support for local adaptation in response to temperature as a possible mechanism for hypertension.


Join 25,000 people in helping redefine health with health concierge and precision medicine.

https://clubalthea.com/2016/10/14/your-complete-dna-sequence-will-help-shape-the-future-of-medicine/

SweGen: A whole-genome map of genetic variability in a cross-section of the Swedish population

Here we describe the SweGen dataset, a high-quality map of genetic variation in the Swedish population. This data represents a basic resource for clinical genetics laboratories as well as for sequencing-based association studies, by providing information on the frequencies of genetic variants in a cohort that is well matched to national patient cohorts.

To select samples for this study, we first examined the genetic structure of the Swedish population using high-density SNP-array data from a nation-wide population based cohort of over 10,000 individuals. From this sample collection, 1,000 individuals, reflecting a cross-section of the population and capturing the main genetic structure, were selected for whole genome sequencing (WGS).

Analysis pipelines were developed for automated alignment, variant calling and quality control of the sequencing data. This resulted in a whole-genome map of aggregated variant frequencies in the Swedish population that we hereby release to the scientific community.

Adam Ameur, Johan Dahlberg, Pall Olason, Francesco Vezzi, Robert Karlsson, Par Lundin, Huiwen Che, JessadaThutkawkorapin, Andreas Kusalananda Kahari, Mats Dahlberg, Johan Viklund, Jonas Hagberg, Niclas Jareborg,Inger Jonasson, Asa Johansson, Sverker Lundin, Daniel Nilsson, Bjorn Nystedt, Patrik Magnusson, Ulf Gyllensten

Rare Functional Variant in TM2D3 is Associated with Late-Onset Alzheimer’s Disease , Icelandic study

We performed an exome-wide association analysis in 1393 late-onset Alzheimer’s disease (LOAD) cases and 8141 controls from the CHARGE consortium. We found that a rare variant (P155L) in TM2D3 was e…

Source: Rare Functional Variant in TM2D3 is Associated with Late-Onset Alzheimer’s Disease , Icelandic study

Rare Functional Variant in TM2D3 is Associated with Late-Onset Alzheimer’s Disease , Icelandic study

We performed an exome-wide association analysis in 1393 late-onset Alzheimer’s disease (LOAD) cases and 8141 controls from the CHARGE consortium. We found that a rare variant (P155L) in TM2D3 was enriched in Icelanders (~0.5% versus <0.05% in other European populations). In 433 LOAD cases and 3903 controls from the Icelandic AGES sub-study, P155L was associated with increased risk and earlier onset of LOAD [odds ratio (95% CI) = 7.5 (3.5–15.9), p = 6.6×10-9].

Mutation in the Drosophila TM2D3 homolog, almondex, causes a phenotype similar to loss of Notch/Presenilin signaling.

Human TM2D3 is capable of rescuing these phenotypes, but this activity is abolished by P155L, establishing it as a functionally damaging allele.

Our results establish a rare TM2D3 variant in association with LOAD susceptibility, and together with prior work suggests possible links to the β-amyloid cascade.

ice.JPG

Summary

Alzheimer’s disease (AD) is the most common cause of dementia in the older adult population. There is substantial evidence for an important genetic contribution to AD risk. While prior work has comprehensively evaluated the contribution of common genetic variants in large population-based cohorts, the role of rare variants remains to be defined. Here, we have used a newer genotyping array to characterize less common variants, including those likely to impact the function of encoded proteins, in a combined cohort of 1393 AD cases and 8141 control subjects without AD. Our results implicate a novel, amino acid-changing variant, P155L, in theTM2D3 gene. This variant was discovered to be more common in the Icelandic population, where it was significantly associated with both increased risk and earlier age of onset of AD. Lastly, in order to examine the potential functional impact of the implicated variant, we performed additional studies in the fruit fly. Our results suggest that P155L causes a loss-of-function in TM2D3, in the context of Notch-Presenilin signal transduction. In sum, we identify a novel, rare TM2D3 variant in association with AD risk and highlight functional connections with AD-relevant biology.

In summary, we have identified a missense mutation in the TM2D3 gene with a strong impact on LOAD risk. The TM2D3 variant is enriched ~10-fold and associated with both risk and age-at-onset of LOAD in the Icelandic population. We further show that P155L is associated with a loss-of-function in the heterologous but potentially relevant context of Notch signaling inDrosophila embryos. We therefore speculate that TM2D3 may participate in the proteolytic processing of both Notch and APP, linking it to the amyloid cascade like other well-established AD susceptibility variants. Although we have demonstrated an association of the TM2D3 variant only in the Icelandic population, our findings may thus have broader implications for understanding LOAD.

http://journals.plos.org/plosgenetics/article?id=10.1371/journal.pgen.1006327#sec002

Join 25,000 people in helping redefine health with health concierge and precision medicine.

https://clubalthea.com/2016/10/14/your-complete-dna-sequence-will-help-shape-the-future-of-medicine/